Autumn Glory Partners LLC Buys 35,600 Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA)

Autumn Glory Partners LLC grew its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 356.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 45,600 shares of the real estate investment trust's stock after buying an additional 35,600 shares during the quarter. Autumn Glory Partners LLC's holdings in Sabra Healthcare REIT were worth $797,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in SBRA. JPMorgan Chase & Co. raised its position in Sabra Healthcare REIT by 4.3% during the fourth quarter. JPMorgan Chase & Co. now owns 10,312,991 shares of the real estate investment trust's stock valued at $178,621,000 after purchasing an additional 426,074 shares during the period. Geode Capital Management LLC increased its position in shares of Sabra Healthcare REIT by 1.4% during the 4th quarter. Geode Capital Management LLC now owns 6,381,525 shares of the real estate investment trust's stock valued at $110,550,000 after purchasing an additional 86,727 shares during the last quarter. Northern Trust Corp increased its position in shares of Sabra Healthcare REIT by 27.7% during the 4th quarter. Northern Trust Corp now owns 4,169,385 shares of the real estate investment trust's stock valued at $72,214,000 after purchasing an additional 905,466 shares during the last quarter. Bank of New York Mellon Corp increased its position in shares of Sabra Healthcare REIT by 13.0% during the 4th quarter. Bank of New York Mellon Corp now owns 4,039,651 shares of the real estate investment trust's stock valued at $69,967,000 after purchasing an additional 463,601 shares during the last quarter. Finally, Janus Henderson Group PLC increased its position in shares of Sabra Healthcare REIT by 23.1% during the 4th quarter. Janus Henderson Group PLC now owns 3,504,809 shares of the real estate investment trust's stock valued at $60,720,000 after purchasing an additional 657,950 shares during the last quarter. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Trading Down 0.2%

Shares of SBRA traded down $0.03 during trading hours on Friday, reaching $18.25. 3,343,753 shares of the company traded hands, compared to its average volume of 2,288,680. The firm has a market cap of $4.34 billion, a price-to-earnings ratio of 30.93, a PEG ratio of 1.38 and a beta of 0.85. Sabra Healthcare REIT, Inc. has a 12-month low of $14.63 and a 12-month high of $20.03. The stock's fifty day moving average price is $17.79 and its 200 day moving average price is $17.26. The company has a current ratio of 4.22, a quick ratio of 4.22 and a debt-to-equity ratio of 0.89.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last released its quarterly earnings data on Monday, May 5th. The real estate investment trust reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.01. The company had revenue of $183.54 million during the quarter, compared to analysts' expectations of $180.23 million. Sabra Healthcare REIT had a net margin of 19.55% and a return on equity of 5.14%. The firm's quarterly revenue was up 10.1% on a year-over-year basis. During the same period in the previous year, the company earned $0.35 EPS. Sell-side analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, May 30th. Shareholders of record on Friday, May 16th were paid a $0.30 dividend. The ex-dividend date was Friday, May 16th. This represents a $1.20 dividend on an annualized basis and a yield of 6.58%. Sabra Healthcare REIT's dividend payout ratio is currently 203.39%.

Insiders Place Their Bets

In other Sabra Healthcare REIT news, Director Michael J. Foster sold 11,000 shares of the stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $18.22, for a total transaction of $200,420.00. Following the transaction, the director now directly owns 64,725 shares in the company, valued at $1,179,289.50. This represents a 14.53% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.20% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on SBRA. Scotiabank boosted their target price on Sabra Healthcare REIT from $18.00 to $19.00 and gave the company a "sector perform" rating in a research report on Monday, May 12th. Truist Financial increased their price objective on shares of Sabra Healthcare REIT from $17.00 to $18.00 and gave the stock a "hold" rating in a research report on Tuesday, March 18th. Three analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $19.50.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.